Immunovant stock falls 8% amid Graves’ disease program update Source: Seekingalpha
Browsing: update
designer491/iStock by way of Getty Images Immunovant (NASDAQ:IMVT) stock fell 8% Monday after it reported knowledge from a Phase 2a research of batoclimab within the therapy…
Applied DNA stock jumps amid U.S. government mpox update Source: Seekingalpha
Janux initiated at Stifel with Buy on upcoming data update Source: Seekingalpha
Applied DNA stock jumps amid U.S. government mpox update Source: Seekingalpha
Janux initiated at Stifel with Buy on upcoming data update Source: Seekingalpha
Applied DNA stock jumps amid U.S. government mpox update Source: Seekingalpha
Janux initiated at Stifel with Buy on upcoming data update Source: Seekingalpha
Avadel says court denies Jazz Pharma request on lumryz in narcolepsy (replace) Source: Seekingalpha
(*3*) Palatin stock climbs 8% on Phase 3 testing update for PL9643 Source: Seekingalpha